CHECK: A randomized trial evaluating the efficacy and cost-effectiveness of home visitation in pediatric weight loss treatment.


Journal

Contemporary clinical trials
ISSN: 1559-2030
Titre abrégé: Contemp Clin Trials
Pays: United States
ID NLM: 101242342

Informations de publication

Date de publication:
01 2020
Historique:
received: 26 06 2019
revised: 06 11 2019
accepted: 13 11 2019
pubmed: 20 11 2019
medline: 27 5 2021
entrez: 20 11 2019
Statut: ppublish

Résumé

Socioeconomically-disadvantaged households have a high prevalence of pediatric overweight/obesity, and also face barriers to accessing weight loss treatment in healthcare settings. Delivering family-based pediatric weight loss treatment in the home setting may enhance its efficacy by facilitating treatment attendance, enabling more tailored treatment recommendations informed by observations of the home environment, and increasing accountability. This paper describes the design of the Creating Health Environments for Chicago Kids (CHECK) Trial, which evaluates the efficacy, cost-effectiveness, and mechanisms of home visitation in family-based pediatric weight loss treatment for children in low-income households. CHECK is a two-arm, parallel group, randomized controlled trial that is enrolling N = 266 children, ages 6-12 y, who have overweight/obesity (BMI percentile ≥85) and live in a low-income household. Participants are randomized in a 1:1 ratio to either standard of care family-based weight loss treatment delivered in the home, or the identical intervention delivered in an academic medical center. The primary outcome is change in child BMI z-score from baseline to 12 months. Program delivery costs are rigorously documented to enable cost-effectiveness analyses from the societal and payer perspectives. Objectively-documented changes to the home environment and aspects of intervention delivery (e.g., hours of in-person contact received, quantity of behavioral goals set per session) will be tested as hypothesized treatment mechanisms. Findings will inform the design of future interventions, and treatment dissemination decisions by public health agencies and third-party payers. ClinicalTrials.gov identifier: NCT03195790.

Sections du résumé

BACKGROUND
Socioeconomically-disadvantaged households have a high prevalence of pediatric overweight/obesity, and also face barriers to accessing weight loss treatment in healthcare settings. Delivering family-based pediatric weight loss treatment in the home setting may enhance its efficacy by facilitating treatment attendance, enabling more tailored treatment recommendations informed by observations of the home environment, and increasing accountability. This paper describes the design of the Creating Health Environments for Chicago Kids (CHECK) Trial, which evaluates the efficacy, cost-effectiveness, and mechanisms of home visitation in family-based pediatric weight loss treatment for children in low-income households.
DESIGN
CHECK is a two-arm, parallel group, randomized controlled trial that is enrolling N = 266 children, ages 6-12 y, who have overweight/obesity (BMI percentile ≥85) and live in a low-income household. Participants are randomized in a 1:1 ratio to either standard of care family-based weight loss treatment delivered in the home, or the identical intervention delivered in an academic medical center. The primary outcome is change in child BMI z-score from baseline to 12 months. Program delivery costs are rigorously documented to enable cost-effectiveness analyses from the societal and payer perspectives. Objectively-documented changes to the home environment and aspects of intervention delivery (e.g., hours of in-person contact received, quantity of behavioral goals set per session) will be tested as hypothesized treatment mechanisms.
IMPLICATIONS
Findings will inform the design of future interventions, and treatment dissemination decisions by public health agencies and third-party payers.
TRIAL REGISTRATION
ClinicalTrials.gov identifier: NCT03195790.

Identifiants

pubmed: 31740429
pii: S1551-7144(19)30606-8
doi: 10.1016/j.cct.2019.105891
pmc: PMC6952551
mid: NIHMS1544120
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03195790']

Types de publication

Clinical Trial Protocol Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

105891

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK111358
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

J Am Diet Assoc. 2009 Apr;109(4):730-4
pubmed: 19328271
J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86
pubmed: 11132119
Clin Obes. 2018 Feb;8(1):68-79
pubmed: 29224232
Metabolism. 1996 Feb;45(2):235-40
pubmed: 8596496
Int J Behav Nutr Phys Act. 2009 Mar 12;6:14
pubmed: 19284631
Atherosclerosis. 2009 Nov;207(1):174-80
pubmed: 19442975
Fam Community Health. 2009 Jan-Mar;32(1):58-75
pubmed: 19092435
J Pediatr Psychol. 2014 Sep;39(8):809-25
pubmed: 24824614
Obes Rev. 2001 Aug;2(3):159-71
pubmed: 12120101
Int J Pediatr Obes. 2009;4(4):266-73
pubmed: 19922041
J Am Diet Assoc. 2002 Dec;102(12):1764-72
pubmed: 12487538
Contemp Clin Trials. 2014 May;38(1):59-68
pubmed: 24480729
Int J Behav Nutr Phys Act. 2008 Nov 04;5:55
pubmed: 18983668
Matern Child Health J. 2015 Oct;19(10):2147-58
pubmed: 25680701
Public Health Nutr. 2012 Jan;15(1):97-109
pubmed: 21899786
Psychol Sci. 2007 Mar;18(3):233-9
pubmed: 17444920
Health Econ. 1998 Mar;7(2):143-7
pubmed: 9565170
Behav Res Methods. 2012 Sep;44(3):806-44
pubmed: 22311738
Arch Dis Child. 2010 Apr;95(4):256-61
pubmed: 19966092
N Engl J Med. 1992 Nov 5;327(19):1350-5
pubmed: 1406836
Obes Rev. 2016 Oct;17(10):977-88
pubmed: 27231126
Pediatrics. 2011 Feb;127(2):214-22
pubmed: 21262890
Int J Obes (Lond). 2011 Jul;35(7):891-8
pubmed: 20975725
J Clin Epidemiol. 2009 May;62(5):464-75
pubmed: 19348971
Pediatrics. 1996 Jan;97(1):26-32
pubmed: 8545220
BMC Med. 2009 Sep 18;7:49
pubmed: 19765270
Am J Prev Med. 2008 Sep;35(3):249-52
pubmed: 18617353
Stat Med. 2012 Jul 10;31(15):1554-71
pubmed: 22359232
Sleep. 2003 Mar 15;26(2):213-6
pubmed: 12683482
BMC Pediatr. 2011 May 27;11:47
pubmed: 21619652
Obesity (Silver Spring). 2011 Mar;19(3):574-80
pubmed: 20966907
Int J Pediatr Otorhinolaryngol. 2014 Dec;78(12):2116-20
pubmed: 25305064
Pediatrics. 2015 Aug;136(2):281-9
pubmed: 26195541
Front Psychol. 2015 Nov 12;6:1732
pubmed: 26617555
Cochrane Database Syst Rev. 2017 Jun 22;6:CD012651
pubmed: 28639319
Obes Rev. 2011 Feb;12(2):114-30
pubmed: 20406416
Pediatrics. 2007 Mar;119(3):517-25
pubmed: 17332205
J Am Diet Assoc. 2006 Mar;106(3):367-73
pubmed: 16503225
JAMA Pediatr. 2015 Jun;169(6):535-42
pubmed: 25895016
Pediatr Phys Ther. 2015 Summer;27(2):113-8
pubmed: 25674882
MMWR Morb Mortal Wkly Rep. 2018 Feb 16;67(6):186-189
pubmed: 29447142
Int J Behav Nutr Phys Act. 2017 Nov 15;14(1):157
pubmed: 29141651
Obesity (Silver Spring). 2017 Jan;25(1):16-29
pubmed: 27925451
Sleep. 2018 Apr 1;41(4):
pubmed: 29401314
Health Serv Res. 2006 Apr;41(2):507-31
pubmed: 16584462
Pediatr Obes. 2019 Mar;14(3):e12477
pubmed: 30378768
Pediatrics. 2013 Jul;132(1):e193-200
pubmed: 23753095
Arch Pediatr Adolesc Med. 2008 Dec;162(12):1119-25
pubmed: 19047538
Assessment. 2011 Sep;18(3):263-83
pubmed: 21697139
J Youth Adolesc. 1988 Apr;17(2):117-33
pubmed: 24277579
Contemp Clin Trials. 2008 Jan;29(1):56-69
pubmed: 17600772
JBI Database System Rev Implement Rep. 2019 Jul;17(7):1341-1427
pubmed: 31021970
J Pediatr. 2013 Sep;163(3):785-90
pubmed: 23706362
J Public Health (Oxf). 2014 Sep;36(3):476-89
pubmed: 24273229
Obesity (Silver Spring). 2011 Oct;19(10):2082-8
pubmed: 21212771
MMWR Recomm Rep. 2013 Mar 1;62(RR-1):1-20
pubmed: 23446553
Public Health Nurs. 2014 Sep-Oct;31(5):405-13
pubmed: 24438361
Circulation. 2012 Mar 6;125(9):1186-207
pubmed: 22271754
Multivariate Behav Res. 2004 Jan 1;39(1):99
pubmed: 20157642
Behav Sci (Basel). 2019 Apr 12;9(4):null
pubmed: 31013841
Int J Behav Nutr Phys Act. 2017 Aug 24;14(1):113
pubmed: 28836983
Int J Behav Nutr Phys Act. 2008 Apr 29;5:24
pubmed: 18445280
Psychosom Med. 2006 May-Jun;68(3):427-36
pubmed: 16738075
Psychosom Med. 2013 Feb;75(2):100-2
pubmed: 23362502
Obes Rev. 2017 May;18(5):581-593
pubmed: 28273680
Arch Pediatr Adolesc Med. 2006 Feb;160(2):128-36
pubmed: 16461867
Arch Pediatr Adolesc Med. 2010 Jan;164(1):9-15
pubmed: 20048236

Auteurs

B M Appelhans (BM)

Department of Preventive Medicine, Rush University Medical Center, United States of America; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, United States of America. Electronic address: brad_appelhans@rush.edu.

S A French (SA)

Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, United States of America.

L E Bradley (LE)

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, United States of America.

K Lui (K)

Department of Pediatrics, Rush University Medical Center, United States of America.

I Janssen (I)

Department of Preventive Medicine, Rush University Medical Center, United States of America.

D Richardson (D)

Department of Preventive Medicine, Rush University Medical Center, United States of America; Department of Mathematics and Computer Science, Lake Forest College, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH